TGF-β1–containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis
Journal of the American Society of Nephrology, 2013•journals.lww.com
Hypoxia is associated with tissue injury and fibrosis but its functional role in fibroblast
activation and tissue repair/regeneration is unknown. Using kidney injury as a model
system, we demonstrate that injured epithelial cells produce an increased number of
exosomes with defined genetic information to activate fibroblasts. Exosomes released by
injured epithelial cells promote proliferation, α-smooth muscle actin expression, F-actin
expression, and type I collagen production in fibroblasts. Fibroblast activation is dependent …
activation and tissue repair/regeneration is unknown. Using kidney injury as a model
system, we demonstrate that injured epithelial cells produce an increased number of
exosomes with defined genetic information to activate fibroblasts. Exosomes released by
injured epithelial cells promote proliferation, α-smooth muscle actin expression, F-actin
expression, and type I collagen production in fibroblasts. Fibroblast activation is dependent …
Abstract
Hypoxia is associated with tissue injury and fibrosis but its functional role in fibroblast activation and tissue repair/regeneration is unknown. Using kidney injury as a model system, we demonstrate that injured epithelial cells produce an increased number of exosomes with defined genetic information to activate fibroblasts. Exosomes released by injured epithelial cells promote proliferation, α-smooth muscle actin expression, F-actin expression, and type I collagen production in fibroblasts. Fibroblast activation is dependent on exosomes delivering TGF-β1 mRNA among other yet to be identified moieties. This study suggests that TGF-β1 mRNA transported by exosomes constitutes a rapid response to initiate tissue repair/regenerative responses and activation of fibroblasts when resident parenchyma is injured. The results also inform potential utility of exosome-targeted therapies to control tissue fibrosis.
